HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, today announced that Ann F. Hanham, Ph.D., a director since August 2016, has been appointed to the Chair of the company’s board of directors.Continue reading
Author Archive: AZBio
Biodesign Institute researcher a pioneer in personalized medicine field
AZBio Board Member, Joshua L. LaBaer, MD, PhD, is being honored at Founders’ Day with the Faculty Research Achievement Award for his groundbreaking work in the emerging field of personalized medicine.Continue reading
NuvOx Pharma and the University of Arkansas Initiate Phase Ib/II Clinical Trial in Stroke
NuvOx Pharma announces that the first patients have been dosed in a Phase Ib/II clinical trial for NVX-208, an oxygen therapeutic being developed for acute ischemic stroke.Continue reading
PCH reports on Innovative Treatment for Children with Frequent Migraine Headaches
Interventional radiology method is safe and effective within minutes, with no complicationsContinue reading
Get the Facts on Drug Costs at DrugCostFacts.org
The Biotechnology Innovation Organization (BIO) launched DrugCostFacts.org on March 2, 2017. This new interactive web tool is designed to help healthcare stakeholders gain a better understanding of the true facts surrounding drug costs, spending and value.
Sharing Arizona Bioindustry News in Washington DC
AZBio delivered data on life-changing innovation and the economic impact of Arizona’s life sciences industry to Arizona’s Congressional Delegation last week in meetings with 10 of Arizona’s 11 Congressional offices.
Longtime Arizona leader Jack Jewett to retire as Flinn Foundation CEO
Jack B. Jewett will retire as Flinn Foundation President and CEO at the end of September, concluding more than eight years of service in which the foundation expanded and enhanced its program areas to better serve Arizona.Continue reading
HTG Molecular Diagnostics Unveils New Direct-Target Sequencing Chemistry to Launch in First Quarter 2017
HTG Molecular Diagnostics Unveils New Direct-Target Sequencing Chemistry to Launch in First Quarter 2017Continue reading